PG
BIIB icon

Pendal Group’s Biogen BIIB Stock Holding History

Pendal Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,914
Closed -$3.71M – 493
2022
Q3 		$3.71M Buy
13,914
+9,429
+210% +$2M 0.04% 158
2022
Q2 		$915K Sell
4,485
-2,668
-37% -$545K 0.01% 286
2022
Q1 		$1.51M Buy
7,153
+4,111
+135% +$894K 0.01% 295
2021
Q4 		$730K Buy
3,042
+1,608
+112% +$413K 0.01% 380
2021
Q3 		$406K Sell
1,434
-104
-7% -$34.1K ﹤0.01% 438
2021
Q2 		$533K Sell
1,538
-11,805
-88% -$3.58M ﹤0.01% 406
2021
Q1 		$3.73M Buy
13,343
+446
+3% +$120K 0.04% 164
2020
Q4 		$3.16M Sell
12,897
-14,116
-52% -$3.64M 0.03% 157
2020
Q3 		$7.66M Sell
27,013
-8,025
-23% -$2.24M 0.09% 85
2020
Q2 		$9.38M Buy
35,038
+12,780
+57% +$3.84M 0.13% 73
2020
Q1 		$7.04M Sell
22,258
-25,873
-54% -$7.85M 0.12% 74
2019
Q4 		$14.3M Sell
48,131
-25,729
-35% -$7.14M 0.19% 63
2019
Q3 		$17.2M Sell
73,860
-25,718
-26% -$5.99M 0.22% 55
2019
Q2 		$23.3M Buy
99,578
+2,105
+2% +$486K 0.32% 52
2019
Q1 		$23M Buy
97,473
+40,443
+71% +$12.7M 0.32% 54
2018
Q4 		$17.2M Sell
57,030
-10,282
-15% -$3.28M 0.27% 63
2018
Q3 		$23.8M Buy
67,312
+20,513
+44% +$7.06M 0.32% 56
2018
Q2 		$13.6M Buy
46,799
+2,273
+5% +$639K 0.18% 89
2018
Q1 		$12.2M Sell
44,526
-2,032
-4% -$631K 0.16% 92
2017
Q4 		$14.8M Buy
46,558
+4,520
+11% +$1.45M 0.19% 88
2017
Q3 		$13.2M Sell
42,038
-1,372
-3% -$406K 0.17% 97
2017
Q2 		$11.8M Buy
+43,410
New +$11.5M 0.17% 99

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pendal Group's BIIB Position: Q4 2022 in Review

Pendal Group sold out of Biogen (BIIB) in Q4 2022, closing a stake of 13,914 shares — an estimated $3.71M sold.

Pendal Group first reported a position in BIIB in Q2 2017 and held it in 22 quarters. The position peaked at $23.8M in Q3 2018. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Pendal Group reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Pendal Group sold 13,914 Biogen shares in Q4 2022, an estimated $3.71M.
  • Pendal Group first reported a position in Biogen in Q2 2017 and held it in 22 quarters.
  • Pendal Group's Biogen position peaked at $23.8M in Q3 2018.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.